Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosinobu Onuma

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Circulation|February 24, 2011
Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization?Yosinobu Onuma, Patrick W Serruys
Circulation Journal : Official Journal of the Japanese Circulation Society|February 9, 2011
Bioresorbable scaffold technologiesYosinobu Onuma, John Ormiston, Patrick W Serruys
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 2, 2010
Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trialYosinobu Onuma, Patrick W Serruys, John A Ormiston, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Circulation|February 24, 2011
Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization?Yosinobu Onuma, Patrick W Serruys
Circulation Journal : Official Journal of the Japanese Circulation Society|February 9, 2011
Bioresorbable scaffold technologiesYosinobu Onuma, John Ormiston, Patrick W Serruys
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 2, 2010
Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trialYosinobu Onuma, Patrick W Serruys, John A Ormiston, et al.
Pageof 1